Longboard Pharmaceuticals Inc

Longboard Pharmaceuticals Inc is a United States-based clinical-stage biotechnology company focused on developing novel, small molecule product candidates. Its primary aim is to address neurological diseases with significant unmet medical needs. The company's operations have a global perspective. Operating within the biotechnology and healthcare sectors, Longboard Pharmaceuticals Inc concentrates on discovering and advancing therapeutics. The company's specific approach involves targeting G protein-coupled receptors (GPCRs) to potentially provide new, effective treatment options for patients. Explore LBPH share prices and other stocks on eToro. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.